These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29487722)

  • 41. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications.
    Vassos N; Agaimy A; Hohenberger W; Croner RS
    Int J Surg; 2014; 12(5):371-7. PubMed ID: 24632413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic and clinicopathological significance of the Prognostic Nutritional Index in patients with gastrointestinal stromal tumours undergoing surgery: a meta-analysis.
    Kang N; Gu H; Ni Y; Wei X; Zheng S
    BMJ Open; 2022 Dec; 12(12):e064577. PubMed ID: 36456008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete wedge resection for duodenal gastrointestinal stromal tumour: A case series of three patients.
    Ito T; Kushida T; Sakurada M; Tanaka K; Sato K; Maekawa H
    Int J Surg Case Rep; 2022 Jan; 90():106674. PubMed ID: 34902701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M; Lasota J
    Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastrointestinal stromal tumour of stomach: Feasibility of laparoscopic resection in large lesions and its long-term outcomes.
    Parthasarathi ; Dhawal S; Chittawadagi B; Cumar B; Kumar S; Palanivelu C
    J Minim Access Surg; 2020; 16(4):348-354. PubMed ID: 32098941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors.
    Novitsky YW; Kercher KW; Sing RF; Heniford BT
    Ann Surg; 2006 Jun; 243(6):738-45; discussion 745-7. PubMed ID: 16772777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours.
    Agaimy A; Wünsch PH
    Langenbecks Arch Surg; 2006 Aug; 391(4):322-9. PubMed ID: 16402273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peritonitis secondary to spontaneous perforation of a primary gastrointestinal stromal tumour of the small intestine: A case report and a literature review.
    Alessiani M; Gianola M; Rossi S; Perfetti V; Serra P; Zelaschi D; Magnani E; Cobianchi L
    Int J Surg Case Rep; 2015; 6C():58-62. PubMed ID: 25524303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Giant gastrointestinal stromal tumour of rare sarcomatoid epithelioid subtype: case study and literature review.
    Lech G; Korcz W; Kowalczyk E; Guzel T; Radoch M; Krasnodębski IW
    World J Gastroenterol; 2015 Mar; 21(11):3388-93. PubMed ID: 25805949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors affecting survival after surgical resection of gastrointestinal stromal tumours: a two-unit experience over 10 years.
    Chiappa A; Zbar AP; Innis M; Garriques S; Bertani E; Biffi R; Pruneri G; Luzzato F; Vigna PD; Trovato C; Andreoni B
    World J Surg Oncol; 2006 Oct; 4():73. PubMed ID: 17029627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.
    Bertsimas D; Margonis GA; Sujichantararat S; Koulouras A; Ma Y; Antonescu CR; Brennan MF; Martín-Broto J; Tang S; Rutkowski P; Kreis ME; Beyer K; Wang J; Bylina E; Sobczuk P; Gutierrez A; Jadeja B; Tap WD; Chi P; Singer S
    Lancet Oncol; 2024 Aug; 25(8):1025-1037. PubMed ID: 38976997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastrointestinal Stromal Tumours (GIST): Indian Experience of Rare Malignancy.
    Malik K; Seshadri RA; Sundersingh S; Dhanushkodi M
    Indian J Surg Oncol; 2020 Sep; 11(3):348-354. PubMed ID: 33013109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Factors of Patients with Gastric Gastrointestinal Stromal Tumor after Curative Resection: A Retrospective Analysis of 406 Consecutive Cases in a Multicenter Study.
    Kim IH; Kwak SG; Chae HD
    Eur Surg Res; 2015; 55(1-2):12-23. PubMed ID: 25766570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal Stromal Tumors (GIST): A Population-Based Study Using the SEER Database, including Management and Recent Advances in Targeted Therapy.
    Khan J; Ullah A; Waheed A; Karki NR; Adhikari N; Vemavarapu L; Belakhlef S; Bendjemil SM; Mehdizadeh Seraj S; Sidhwa F; Ghleilib I; Foroutan S; Blakely AM; Del Rivero J; Karim NA; Vail E; Heneidi S; Mesa H
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of tumour rupture risk on the oncological rationale for the surgical treatment choice of gastrointestinal stromal tumours.
    Peparini N
    World J Gastrointest Surg; 2023 Aug; 15(8):1559-1563. PubMed ID: 37701682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients.
    Bischof DA; Kim Y; Dodson R; Jimenez MC; Behman R; Cocieru A; Fisher SB; Groeschl RT; Squires MH; Maithel SK; Blazer DG; Kooby DA; Gamblin TC; Bauer TW; Quereshy FA; Karanicolas PJ; Law CH; Pawlik TM
    JAMA Surg; 2015 Apr; 150(4):299-306. PubMed ID: 25671681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HER4 is a novel prognostic biomarker in gastrointestinal stromal tumor specifically originated from stomach.
    Zhao WY; Zhuang C; Xu J; Wang M; Zhang ZZ; Tu L; Wang CJ; Ling TL; Cao H; Zhang ZG
    Am J Cancer Res; 2014; 4(6):838-49. PubMed ID: 25520872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.